Drug selection for lung cancer therapy using antibody-based...

Details Drug selection for lung cancer therapy using antibody-based... Drug selection for lung cancer therapy using antibody-based...

G - Physics

01

N

G01N 33/574 (2006.01) C12Q 1/00 (2006.01)

Patent

CA 2693013

The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.

La présente invention concerne des compositions et de procédés permettant de détecter les états d'activation de composants des voies de transduction de signal dans des cellules de tumeur. Des informations sur les états d'activation de composants de voies de transduction de signal dérivées de l'utilisation de l'invention peuvent être utilisées pour un diagnostic de cancer, un pronostic de cancer et dans la conception de traitements du cancer.

Affiliated with

Also associated with

Rating

Drug selection for lung cancer therapy using antibody-based... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug selection for lung cancer therapy using antibody-based..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug selection for lung cancer therapy using antibody-based... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1448094